Trial
NCT00292747
Drotaverine in Dysmenorrhoea Treatment
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Dysmenorrhea
Intervention
Drotaverine
Why stopped
early termination due to loss of interest and low enrollment of patient
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-08